Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 8/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | APAF1 | O14727 | 1/20 | 0.38 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | GRM6 | O15303 | 1/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2728002 | 0.72 | PTPN11 (0.48) | PTPN11PTPN1ALDH1A1KDM4ETXNRD1 | |
| SCHEMBL14446371 | 0.71 | KDM4E (0.42) | PTPN11PTPN1PTPN6ALDH1A1MAPT | |
| SCHEMBL30352788 | 0.70 | ALDH1A1 (0.39) | ALDH1A1MAPTPOLBTHRBBLM | |
| SCHEMBL25991821 | 0.70 | ALDH1A1 (0.39) | ALDH1A1MAPTPOLBTHRBBLM | |
| SCHEMBL12366184 | 0.70 | ALDH1A1 (0.46) | ALDH1A1MAPTPOLBTHRBBLM | |
| SCHEMBL29397592 | 0.70 | ALDH1A1 (0.39) | ALDH1A1MAPTPOLBTHRBBLM | |
| SCHEMBL56906 | 0.69 | USP8 (0.40) | ALDH1A1MAPTMEN1KMT2ANPSR1 | |
| SCHEMBL4261991 | 0.68 | TRPV4 (0.32) | MAPTMEN1KMT2AKDM4E | |
| SCHEMBL7061881 | 0.68 | MAPT (0.39) | PTPN11ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL6108284 | 0.67 | ALDH1A1 (0.43) | ALDH1A1MAPTPOLBTHRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3212655-A1 | PROCESS FOR PREPARING THIADIAZOLO-ISOINDOLE-DIONE DERIVATIVES | Merck Patent GmbH (DE) | 2017-09-06 | — | — | EP | claimed |
| WO-2016066241-A1 | PROCESS FOR PREPARING THIADIAZOLO-ISOINDOLE-DIONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2016-05-06 | — | — | WO | claimed |
| US-20240061332-A1 | METHOD OF PATTERNING SEMICONDUCTOR LAYER | Raynergy Tek Incorporation (TW) | 2024-02-22 | — | — | US | disclosed |
| CN-117580423-A | Method for patterning semiconductor layer | 天光材料科技股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
| US-11183637-B2 | Organic photodetector | Raynergy Tek Incorporation (TW) | 2021-11-23 | — | — | US | disclosed |
| EP-3010992-B1 | CONJUGATED POLYMERS | RAYNERGY TEK INC (TW) | 2021-09-15 | — | — | EP | disclosed |
| US-20180291036-A1 | PROCESS FOR PREPARING THIADIAZOLO-ISOINDOLE-DIONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2018-10-11 | — | — | US | disclosed |
| WO-2018119780-A1 | WEAK ELECTRON-DONATING BUILDING BLOCKS, COPOLYMERS THEREOF AND RELATED DEVICES | SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) | 2018-07-05 | — | — | WO | disclosed |
| US-9837613-B2 | Conjugated polymers | MERCK PATENT GMBH (DE) | 2017-12-05 | — | — | US | disclosed |
| US-9837613-B2 | Conjugated polymers | MERCK PATENT GMBH (DE) | 2017-12-05 | — | — | US | disclosed |
| EP-3212655-A1 | PROCESS FOR PREPARING THIADIAZOLO-ISOINDOLE-DIONE DERIVATIVES | Merck Patent GmbH (DE) | 2017-09-06 | — | — | EP | disclosed |
| US-9153784-B2 | Conjugated polymers | MERCK PATENT GMBH (DE) | 2015-10-06 | — | — | US | disclosed |
| US-20150270490-A1 | CONJUGATED POLYMERS | MERCK PATENT GMBH (DE) | 2015-09-24 | — | — | US | disclosed |
| US-20150270490-A1 | CONJUGATED POLYMERS | MERCK PATENT GMBH (DE) | 2015-09-24 | — | — | US | disclosed |
| US-20150218115-A1 | MATERIALS HAVING ELECTRON DEFICIENT MOIETIES AND METHODS OF SYNTHESIZING THEREOF | NATIONAL SCIENCE FOUNDATION | 2015-08-06 | — | — | US | disclosed |
| US-20150218115-A1 | MATERIALS HAVING ELECTRON DEFICIENT MOIETIES AND METHODS OF SYNTHESIZING THEREOF | NATIONAL SCIENCE FOUNDATION | 2015-08-06 | — | — | US | disclosed |
| EP-2611851-B1 | CONJUGATED POLYMERS | MERCK PATENT GMBH (DE) | 2014-10-29 | — | — | EP | disclosed |
| US-20130161567-A1 | CONJUGATED POLYMERS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2013-06-27 | — | — | US | disclosed |
| US-20130161567-A1 | CONJUGATED POLYMERS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2013-06-27 | — | — | US | disclosed |
| WO-2012028246-A1 | CONJUGATED POLYMERS | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270490-A1 | CONJUGATED POLYMERS | OCIAD2, PARG, PPOX | PTPN11 2609/4885PTPN1 3209/4885PTPN6 3034/4885 |
| US-20180291036-A1 | PROCESS FOR PREPARING THIADIAZOLO-ISOINDOLE-DIONE DERIVATIVES | TDO2, DRD5, DRD4 | PTPN11 2813/4885PTPN1 2841/4885PTPN6 3103/4885 |
| US-20130161567-A1 | CONJUGATED POLYMERS | OCIAD2, PARG, PPOX | PTPN11 2609/4885PTPN1 3209/4885PTPN6 3034/4885 |
| US-20150218115-A1 | MATERIALS HAVING ELECTRON DEFICIENT MOIETIES AND METHODS OF SYNTHESIZING THEREOF | NBAS, EMD, MPO | PTPN11 1668/4885PTPN1 2083/4885PTPN6 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.